Literature DB >> 23969562

Medial septal cholinergic neurons modulate isoflurane anesthesia.

Siew Kian Tai1, Jingyi Ma, L Stan Leung.   

Abstract

BACKGROUND: Cholinergic drugs are known to modulate the response of general anesthesia. However, the sensitivity of isoflurane or other volatile anesthetics after selective lesion of septal cholinergic neurons that project to the hippocampus is not known.
METHODS: Male Long Evans rats had 192 immunoglobulin G-saporin infused into the medial septum (n = 10), in order to selectively lesion cholinergic neurons, whereas control, sham-lesioned rats were infused with saline (n = 12). Two weeks after septal infusion, the hypnotic properties of isoflurane and ketamine were measured using a behavioral endpoint of loss of righting reflex (LORR). Septal lesion was assessed by counting choline acetyltransferase-immunoreactive cells and parvalbumin-immunoreactive cells.
RESULTS: Rats with 192 immunoglobulin G-saporin lesion, as compared with control rats with sham lesion, showed a 85% decrease in choline acetyltransferase-immunoreactive, but not parvalbumin-immunoreactive, neurons in the medial septal area. Lesioned as compared with control rats showed increased isoflurane sensitivity, characterized by a leftward shift of the graph plotting cumulative LORR percent with isoflurane dose. However, lesioned and control rats were not different in their LORR sensitivity to ketamine. When administered with 1.375% isoflurane, LORR induction time was shorter, whereas emergence time was longer, in lesioned as compared with control rats. Hippocampal 62-100 Hz gamma power in the electroencephalogram decreased with isoflurane dose, with a decrease that was greater in lesioned (n = 5) than control rats (n = 5).
CONCLUSIONS: These findings suggest a role of the septal cholinergic neurons in modulating the sensitivity to isoflurane anesthesia, which affects both induction and emergence. The sensitivity of hippocampal gamma power to isoflurane appears to indicate anesthesia (LORR) sensitivity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23969562     DOI: 10.1097/ALN.0b013e3182a7cab6

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

1.  Activation of Dopamine Signals in the Olfactory Tubercle Facilitates Emergence from Isoflurane Anesthesia in Mice.

Authors:  Bo Yang; Yawen Ao; Ying Liu; Xuefen Zhang; Ying Li; Fengru Tang; Haibo Xu
Journal:  Neurochem Res       Date:  2021-03-12       Impact factor: 3.996

2.  Caffeine accelerates recovery from general anesthesia via multiple pathways.

Authors:  Robert Fong; Suhail Khokhar; Atif N Chowdhury; Kelvin G Xie; Josiah Hiu-Yuen Wong; Aaron P Fox; Zheng Xie
Journal:  J Neurophysiol       Date:  2017-06-28       Impact factor: 2.714

3.  Caffeine accelerates recovery from general anesthesia.

Authors:  Qiang Wang; Robert Fong; Peggy Mason; Aaron P Fox; Zheng Xie
Journal:  J Neurophysiol       Date:  2013-12-26       Impact factor: 2.714

4.  The Role of Dopaminergic VTA Neurons in General Anesthesia.

Authors:  Xuelong Zhou; Yin Wang; Chenjing Zhang; Min Wang; Mei Zhang; LiNa Yu; Min Yan
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

5.  Cholinergic Modulation of General Anesthesia.

Authors:  Lai-Wo Stan Leung; Tao Luo
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

Review 6.  Medial Septum Modulates Consciousness and Psychosis-Related Behaviors Through Hippocampal Gamma Activity.

Authors:  L Stan Leung; Jingyi Ma
Journal:  Front Neural Circuits       Date:  2022-07-07       Impact factor: 3.342

7.  Butorphanol suppression of histamine itch is mediated by nucleus accumbens and septal nuclei: a pharmacological fMRI study.

Authors:  Alexandru D P Papoiu; Robert A Kraft; Robert C Coghill; Gil Yosipovitch
Journal:  J Invest Dermatol       Date:  2014-09-11       Impact factor: 8.551

8.  Basal Forebrain Cholinergic Activity Modulates Isoflurane and Propofol Anesthesia.

Authors:  Tian-Yuan Luo; Shuang Cai; Zai-Xun Qin; Shao-Cheng Yang; Yue Shu; Cheng-Xi Liu; Yu Zhang; Lin Zhang; Liang Zhou; Tian Yu; Shou-Yang Yu
Journal:  Front Neurosci       Date:  2020-10-27       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.